A living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacology.
Patient-derived tumor xenograft (PDX)/organoid (PDO), driven by cancer stem cells (CSC), are considered the most predictive models for translational oncology. Large PDX collections reflective of patient populations have been created and used extensively to test various investigational therapies, inc...
Main Authors: | Xiaoxi Xu, Rajendra Kumari, Jun Zhou, Jing Chen, Binchen Mao, Jingjing Wang, Meiling Zheng, Xiaolong Tu, Xiaoyu An, Xiaobo Chen, Likun Zhang, Xiaoli Tian, Haojie Wang, Xin Dong, Zhengzheng Bao, Sheng Guo, Xuesong Ouyang, Limei Shang, Fei Wang, Xuefei Yan, Rui Zhang, Robert G J Vries, Hans Clevers, Qi-Xiang Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0279821 |
Similar Items
-
A living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacology
by: Xiaoxi Xu, et al.
Published: (2023-01-01) -
Living biobank: Standardization of organoid construction and challenges
by: Ruixin Yang, et al.
Published: (2024-12-01) -
Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank
by: Zilong Zhou, et al.
Published: (2021-12-01) -
An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity
by: Camilla Calandrini, et al.
Published: (2020-03-01) -
Living biobank-based cancer organoids: prospects and challenges in cancer research
by: Haixin Li, et al.
Published: (2022-07-01)